Nalaganje...
Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low‐Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison
BACKGROUND. Daratumumab (a human CD38‐directed monoclonal antibody) and pomalidomide (an immunomodulatory drug) plus dexamethasone are both relatively new treatment options for patients with heavily pretreated multiple myeloma. A matching adjusted indirect comparison (MAIC) was used to compare absol...
Shranjeno v:
| izdano v: | Oncologist |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
AlphaMed Press
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5905688/ https://ncbi.nlm.nih.gov/pubmed/29192016 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0103 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|